School of Public Health, College of Medicine and Health Sciences, Wachemo University, Hosanna, Ethiopia.
School of Public Health, Faculty of Medicine, The University of Queensland, Brisbane, Australia.
BMC Cancer. 2024 Aug 26;24(1):1050. doi: 10.1186/s12885-024-12789-3.
Cervical cancer screening is the primary goal in 90-70-90 targets to reduce cervical cancer incidence and mortality by identifying and treating women with precancerous lesions. Although several studies have been conducted in Sub-Saharan African (SSA) countries on cervical cancer screening, their coverage was limited to the regional or national level, and/or did not address individual- and community-level determinants, with existing evidence gaps to the wider SSA region using the most recent data. Hence, this study aimed to assess the pooled prevalence and multilevel correlates of cervical cancer screening among women with SSA.
This study was conducted using the Demographic Health Survey data (2015-2022) from 11 countries, and a total weighted sample of 124,787 women was considered in the analysis. Using multilevel mixed-effects logistic regression, the influence of each factor on cervical cancer screening uptake was investigated, and significant predictors were reported using the adjusted odds ratio (aOR) with their respective 95% confidence intervals (95% CI).
The overall weighted prevalence of cervical cancer screening was 10.29 (95% CI: 7.77, 11.26), with the highest and lowest screening rates detected in Namibia and Benin at 39.3% (95% CI: 38.05, 40.54) and 0.5% (95% CI: 0.36, 0.69), respectively. Higher cervical screening uptake was observed among women aged 35-49 [aOR = 4.11; 95% CI: 3.69, 4.58] compared to 15-24 years, attending higher education [aOR = 2.71; 95% CI: 2.35, 3.23] than no formal education, being in the richest wealth quintile [aOR = 1.45; 95% CI: 1.26, 1.67], having a recent visit to a health facility [aOR = 1.83; 95% CI: 1.71, 1.95], using contraception [aOR = 1.54; 95% CI: 1.45, 1.64], recent sexual activity [aOR = 3.59; 95% CI: 2.97, 4.34], and listening to the radio [aOR = 1.78; 95%CI: 1.60, 2.15].
The overall prevalence of cervical cancer screening in SSA countries was found to be low; only one in every ten women has been screened. Strengthening universal health coverage, and promoting screening programs with an emphasis on rural areas and low socioeconomic status are key to improving screening rates and equity. Additionally, integrating cervical cancer screening with existing reproductive health programs, e.g. contraceptive service would be important.
宫颈癌筛查是 90-70-90 目标的主要目标,通过识别和治疗癌前病变妇女,降低宫颈癌发病率和死亡率。尽管在撒哈拉以南非洲(SSA)国家进行了几项关于宫颈癌筛查的研究,但它们的覆盖范围仅限于区域或国家一级,和/或没有解决个人和社区一级的决定因素,现有的证据差距是更广泛的 SSA 地区使用最新数据。因此,本研究旨在评估 SSA 妇女中宫颈癌筛查的 pooled 患病率和多水平相关性。
本研究使用了来自 11 个国家的人口健康调查(2015-2022)的数据,在分析中考虑了总共 124787 名加权女性的样本。使用多水平混合效应逻辑回归,调查了每个因素对宫颈癌筛查参与的影响,并使用调整后的优势比(aOR)及其各自的 95%置信区间(95%CI)报告了显著的预测因素。
总体加权宫颈癌筛查率为 10.29%(95%CI:7.77%,11.26%),筛查率最高的是纳米比亚,为 39.3%(95%CI:38.05%,40.54%),最低的是贝宁,为 0.5%(95%CI:0.36%,0.69%)。与 15-24 岁相比,35-49 岁的妇女接受宫颈癌筛查的比例更高[aOR=4.11;95%CI:3.69%,4.58%],与没有接受正规教育的妇女相比,接受高等教育的妇女[aOR=2.71;95%CI:2.35%,3.23%],与最富裕的财富五分位数[aOR=1.45;95%CI:1.26%,1.67%],最近到医疗机构就诊[aOR=1.83;95%CI:1.71%,1.95%],使用避孕药具[aOR=1.54;95%CI:1.45%,1.64%],最近有性行为[aOR=3.59;95%CI:2.97%,4.34%],听广播[aOR=1.78;95%CI:1.60%,2.15%]。
在 SSA 国家,宫颈癌筛查的总体流行率较低;每 10 名妇女中只有 1 人接受过筛查。加强全民健康覆盖,并促进以农村地区和低社会经济地位为重点的筛查计划,是提高筛查率和公平性的关键。此外,将宫颈癌筛查与现有的生殖健康方案(如避孕服务)相结合也很重要。